Nightingale Health
2.85
EUR
+2.52 %
4,572 following
HEALTH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.7 | 2.0 | 1.8 | 2.3 | 2.3 | 4.2 | 4.4 | 5.2 | 8.2 | 13.1 | 20.6 |
growth-% | 17.1 % | -13.0 % | 29.4 % | 0.3 % | 80.8 % | 4.2 % | 19.2 % | 58.2 % | 60.0 % | 57.0 % | |
EBITDA | -2.2 | -3.6 | -3.1 | -7.3 | -9.4 | -12.9 | -10.4 | -9.1 | -9.7 | -8.9 | -4.6 |
EBIT (adj.) | -2.5 | -3.8 | -3.3 | -8.6 | -13.6 | -18.5 | -18.6 | -17.3 | -16.2 | -14.4 | -9.6 |
EBIT | -2.5 | -3.8 | -3.3 | -9.8 | -13.6 | -18.5 | -18.6 | -17.3 | -16.2 | -14.4 | -9.6 |
Profit before taxes | -2.6 | -4.0 | -3.7 | -9.7 | -16.2 | -18.2 | -17.4 | -16.3 | -15.5 | -14.2 | -9.6 |
Net income | -2.6 | -4.0 | -3.7 | -9.7 | -16.1 | -18.2 | -17.4 | -16.3 | -15.5 | -13.5 | -9.1 |
EPS (adj.) | -0.21 | -0.23 | -0.30 | -0.29 | -0.27 | -0.25 | -0.22 | -0.15 | |||
growth-% | |||||||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend ratio |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | -127.0 % | -173.5 % | -174.9 % | -316.7 % | -405.9 % | -308.4 % | -239.4 % | -175.5 % | -117.9 % | -67.8 % | -22.1 % |
EBIT-% (adj.) | -140.1 % | -184.7 % | -187.6 % | -375.0 % | -589.5 % | -442.9 % | -426.6 % | -332.6 % | -197.1 % | -109.6 % | -46.3 % |
EBIT-% | -140.1 % | -184.7 % | -187.6 % | -423.2 % | -589.5 % | -442.9 % | -426.6 % | -332.6 % | -197.1 % | -109.6 % | -46.3 % |
ROE | -52.1 % | -62.3 % | -15.0 % | -13.7 % | -17.4 % | -19.3 % | -21.4 % | -24.5 % | -26.1 % | -21.6 % | |
ROI | -24.9 % | -26.1 % | -13.7 % | -11.1 % | -17.1 % | -20.2 % | -22.5 % | -25.6 % | -27.8 % | -22.8 % |